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AN EVALUATION OF COVID-19 VACCINATION RATES
Abstract
COVID-19 vaccines have been widely available to the U.S. public since early 2021. However,
vaccination rates still vary considerably across geographical areas and different populations. The
objective of this study was to research overall vaccination rates against COVID-19 for Latinx
patients at the Kentucky Racing Health Services Center (KRHSC). Vaccination and booster data
was collected from June to December 2021 for all unique patients visiting the center. It was
initially hypothesized that these rates of vaccination and booster doses for the KRHSC patients
would be lower than the data reported by Kentucky and Jefferson County. After a retrospective
review, the results conveyed that the KRHSC patients actually had higher percentages of
vaccination when compared to published values by the state and Jefferson County. However, this
did not hold true for booster vaccinations, as no patients at the KRHSC reported receiving
additional doses against COVID-19. These results suggest that efforts are needed to encourage
higher COVID-19 vaccinations and booster doses in patients at the KRHSC.
Lay Summary
The COVID-19 pandemic has significantly impacted the health and well-being of people across
the world. The rollout of vaccines to provide immunity from the virus causing this pandemic has
differed based on geographical location and economic status. This study aimed to evaluate the
rate of vaccination specifically for the Latinx patients coming to the Kentucky Racing Health
Services Center (KRHSC), which provides primary care to backside racetrack workers at
Churchill Downs. Patient records were evaluated and recorded to determine how many patients
received any type of COVID-19 vaccine. The results demonstrated that more of the KRHSC
patients were fully vaccinated when compared to people across Kentucky and in Jefferson
County. However, fewer of these patients had received booster (or additional) doses.
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An Evaluation of COVID-19 Vaccination Rates of the Patients
at the Kentucky Racing Health Services Center (KRHSC)
The COVID-19 pandemic has put a large strain on medical facilities across the world.
The coronavirus causing this disease, SARS-CoV-2, spreads quickly and efficiently between
human hosts. It has been shown to cause severe health complications, such as pulmonary
thromboembolisms, cardiac irregularities, kidney dysfunction, and cytokine storms by the
immune system (Luigetti & Frisullo, 2020); however, it does not affect all demographic
populations in the same way. In the United States (U.S.), people of color are disproportionately
represented in mortality statistics while making up a slim fraction of the overall population
(Rogers et al., 2020). Latinx (referring to those with Latin American heritage) patients are
disproportionally represented in this manner, with a report stating that Latinx people made up
approximately 33% of new COVID-19 cases, despite only comprising 18% of the U.S.
population (American Medical Association, 2020). This statistic suggests that these vulnerable
communities may not be getting adequate support from public health structures to prevent
symptomatic infections.
The isolation created by lockdowns in the pandemic has also been shown to increase
general stress levels and uncertainty in those living in the U.S. (Park et al., 2020). This may
result in decreased levels of resilience and adherence to public health guidelines in the long run
(Park et al., 2020). Higher levels of stress and mental health issues, coupled with increased sleep
problems and alcohol use, have been observed in minority groups during the pandemic
(MacCarthy et al., 2020). Further, marginalized subgroups within minority groups have felt even
more ostracized from others and their partners during the strict lockdowns of the pandemic
(Ruprecht et al., 2021). For example, Latinx sexual minority men and transgender women have
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reported more interpersonal conflict with partners and other people in their lives due to the
pandemic (MacCarthy et al., 2020). These secondary effects of the COVID-19 pandemic
highlight why spread of this virus needs to be limited in the general population.
Approximately 68,000 people identify as Latinx in the city of Louisville, and Spanish is
the most common language spoken in the city other than English (Data USA, 2019). The
KRHSC specializes in providing essential care to racetrack workers who are members of this
ethnic identity. The author of this thesis was connected to the KRHSC through the Latin
American and Latino Studies (LALS) program at the University of Louisville (UofL). This thesis
is an expansion of a research paper created for the LALS 400 course. As of February 2022, the
author continues to work as an interpreter at the KRHSC.
Introduction
The KRHSC is a nonprofit healthcare center funded by the Kentucky Racing Health and
Welfare Fund (KRHWF). The KRHWF is a non-profit charitable organization that receives its
funding from uncashed or escheated winning tickets at Kentucky’s thoroughbred racetrack on an
annual basis. Enabling legislation to fund this organization was passed by the Kentucky
Legislature in 1978 and can be found in the Kentucky Revised Statutes 230.374, “Payments to
Kentucky Racing Health and Welfare Fund” (Kentucky General Assembly, 1978). The KRHSC
was established in 2005 as a partnership between the KRHWF and the UofL School of Nursing.
The KRHSC assists individuals in the Kentucky thoroughbred racing industry working primarily
on the backside at Churchill Downs. A large majority of these people are primarily non-English
speaking Latinx immigrants of low socioeconomic status with minimal health literacy rates and
no other means to access healthcare services. Patients only have a five-dollar co-pay for
medications, so the KRHSC is an extremely essential option for workers on the racing tracks
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who cannot afford other healthcare options. The primary focus of this community collaboration
is to provide healthcare services to uninsured backside workers at Churchill Downs and their
families. The KRHSC offers primary care, women’s health checkups, and mental health services.
UofL nurse practitioners, who are faculty members at the School of Nursing, provide healthcare
services.
In 2020 alone, even in the midst of the COVID-19 pandemic, KRHSC provided care to
672 racetrack workers and gave over $1.2 million worth of health and retirement benefits to
patients (Kentucky Racing Health Services Center, 2020). In addition to providing healthcare
services, the center has a teaching mission. The center works with various departments at UofL
to coordinate student involvement in patient care. Students from many different disciplines and
degree levels work at the center to simultaneously enhance their education and serve the
community. The KRHSC incorporates teaching, research, and interprofessional practice into a
unique care delivery model. University partners include students from the LALS program, UofL
School of Nursing, and UofL School of Dentistry. These students offer medical and
interpretation services as needed at the center (Kentucky Racing Health Services Center, 2020).
Three COVID-19 vaccines (Pfizer-BioNTech, Johnson & Johnson’s Janssen, and
Moderna-NIAID) have been widely available to the general U.S. public since early 2021. They
have all been shown to be very effective in preventing transmission of COVID-19 to others and
hospitalization of sick individuals (Wu et al., 2021). Additionally, booster vaccinations for all
three-vaccine types became accessible in the U.S. around the end of September 2021 to help
combat the surge of the Delta COVID-19 variant (LaFraniere & Weiland, 2021). The importance
of booster vaccinations against COVID-19 was amplified towards the end of 2021, especially
with the rise of the extremely contagious Omicron variant (Abbott, 2021). Clinical trials have

5

AN EVALUATION OF COVID-19 VACCINATION RATES
indicated that booster doses can enhance immune responses and neutralizing antibodies against
COVID-19 (Spigelman, 2021). The efficacy of booster vaccinations is crucial, especially for
patients that have other comorbidities or who are immunocompromised (Spigelman, 2021). The
Centers for Disease Control and Prevention recommend that those eligible should get a booster
shot at least five months after receiving the last dose of Pfizer-BioNTech or Moderna
vaccinations or at least two months after receiving the Janssen vaccination (2022). Additionally,
people can mix and match their booster shots, but the Pfizer-BioNTech and Moderna
vaccinations are preferred as booster doses in most situations (Centers for Disease Control and
Prevention, 2022).
Along with other medical facilities worldwide, the patients at the KRHSC were heavily
impacted by the COVID-19 pandemic. Vaccine hesitancy among this Latinx population may
have contributed to high infection incidence rates (Armstrong et al., 2007). Several barriers
served as promoters of vaccine hesitancy in this population, the main one being language
differences (Steinberg et al., 2016). Latinx patients often do not have many resources available
for primary care due to a potential language barrier between patients and medical providers;
without trained interpreters, this can often lead to negative health outcomes and higher levels of
medical mistrust in this patient population (Steinberg et al., 2016).
There is also a lack of relevant data relating to Latinx patients in Kentucky’s state
COVID-19 vaccination records. The updated dashboard from the Kentucky Department of
Public Health does not clearly highlight Latinx ethnic identity, as it is not indicated if people
identifying as Latinx are included in the “White” or “Other” racial classification (2022). This
research study could help introduce more statistics about the Latinx population in Kentucky so
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that they are clearly included in vaccination demographics (Kentucky Department of Public
Health, 2022).
Distrust was another barrier that contributed to vaccination hesitancy in the Latinx
population. With regards to the physician-patient relationship, previous univariate and
multivariate analyses have conveyed that minority patients with lower socioeconomic status
reported higher levels of medical distrust overall (Armstrong et al., 2007). While this distrust
tends to vary by geographic region and racial identification, Hispanic and Black patients have
reported decreased trust in the U.S. healthcare system when compared to White patients
(Armstrong et al., 2007). This may be due to racism present in the medical field, more for-profit
care for private investors, and increased instances of abuse toward minority patients by
healthcare providers (Armstrong et al., 2007). The COVID-19 pandemic has specifically
demonstrated the presence of vaccine hesitancy in the general population, which appears to peak
during increased incidence rates of infection (Pullan & Dey, 2021). The rates of reported medical
distrust and vaccine hesitancy were central motivations for conducting this research study, as the
patient population of interest is made up of those with Latinx and Hispanic identities. The
researchers involved in this study kept this in mind while creating the proposed methodology.
To determine the rate of vaccination at the KRHSC, a research study was conducted with
the primarily Latinx patient population. It was hypothesized that the rate of vaccination at the
KRHSC was lower than the average percentage of vaccination in Jefferson County and the state
of Kentucky. This was because the Latinx patient population at the KRHSC was thought to have
a higher level of medical mistrust and vaccine hesitancy, as exemplified through previous studies
(Armstrong et al., 2007; Pullan & Dey, 2021). It was also predicted that social media attitudes
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and other agents of socialization may have contributed to increased vaccine hesitancy for
patients, though these specific variables were not explicitly reviewed in this study.
Methodology
The objective of this study was to analyze COVID-19 vaccination rates of the Latinx
patients served at the KRHSC. Those participating in this research study were adult patients
visiting the KRHSC for primary care services. Patients primarily belonged to the Latinx
community, which includes immigrants from Mexico, Guatemala, Cuba, and Puerto Rico. Each
patient upon initial triage was provided with a “Patient Health Questionnaire,” otherwise known
as the PHQ-2. This was a screening for anhedonia, or the loss of pleasure from normal activities,
and depression to determine whether the patient needs a psychiatric consult. Starting in early
June 2021, while triaging and gathering the PHQ-2 data, a question asking patients if they had
received the COVID-19 vaccination was added. If the patient responded “Yes,” they were then
asked about the approximate month they were vaccinated, and which vaccine type they received.
If they responded “No,” the patient was asked if they would like to receive the vaccine in the
future. The responses patients had to the PHQ-2 and vaccination status were then recorded by the
nurse practitioners on the patient’s Electronic Medical Record (EMR).
A retrospective review of vaccination rates from June to December 2021 was conducted
as part of this study utilizing patient EMRs. The EMR used at the KRHSC is called Practice
Fusion. Medical providers entered the vaccination status of each patient that came to the center
into Practice Fusion under the preventive care section. All patient encounters and EMRs were
captured in a report generated by the KRHSC director and project lead, Dedra Hayden, DNP,
ANP, APRN-C. COVID-19 vaccination status, along with the date and type of vaccination
(Pfizer, Johnson & Johnson, or Moderna), were recorded under each patient’s documented
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summary. This vaccination data was collected during the triage process prior to each visit. All
patient data was de-identified and confidential and all health information was protected. Simple
descriptive statistics were used to analyze all collected data from the EMR and compare it to
publicly available COVID-19 vaccination rates by the Jefferson County and Kentucky
Departments of Public Health.
UofL Institutional Review Board (IRB) approval was obtained by the researchers
involved in this study. Health Insurance Portability and Accountability Act (HIPAA) research
training on working with human subjects was also required and completed for this research study
before accessing data; however, patient informed consent was not required for this study, as no
data was collected directly from patients at the KRHSC. A waiver of consent was utilized. The
only data collected was de-identified data within the EMR. There was no risk, potential harm, or
injury associated with the research that a reasonable person would likely consider significant in
deciding whether or not to participate in the study. The concept of risk includes discomfort,
burden, or inconvenience a subject may experience as a result of the research procedures. All
data was collected electronically and stored on an encrypted computer owned by the
KRHSC. This computer was password protected, maintained in a locked office, and turned
off on a daily basis.
Results
This retrospective review of medical records involved unique patients (N = 237) who
utilized the KRHSC between June and December 2021. The data collected for these patients
included their vaccination status, the vaccine type they received (Pfizer, Moderna, or Johnson &
Johnson), the total doses or boosters they had gotten, and the date of their last vaccination dose.

9

AN EVALUATION OF COVID-19 VACCINATION RATES

10

A sample of the data collection table is provided below, with ID numbers being used to refer to
patients.

Table 1
EMR Data Collection Sample, June to December 2021

Patient
Number

Vaccination
Status (y/n)

Vaccine Type
(Pfizer, Moderna,
J & J)

Dose
Number
1 (y/n)

Dose
Number
2 (y/n)

Booster
Shot (y/n)

Date of Last Dose

122

Yes

J&J

Yes

N/A

No

Mar-21

123

Yes

J&J

Yes

N/A

No

Mar-21

124

No

N/A

No

No

No

N/A

125

Yes

J&J

Yes

N/A

No

Apr-21

126

No

N/A

No

No

No

N/A

127

Yes

Moderna

Yes

Yes

No

Apr-21

128

No

N/A

No

No

No

N/A

A substantial amount of the KRHSC patients (n = 75) reported during the triage process
that they had not received any type of COVID-19 vaccination. This constituted approximately
one-third (31.6%) of the total sample, and the rest of the patients (n = 162) evaluated during this
time period were vaccinated (68.4%). Of those patients who were vaccinated against COVID-19,
a large majority (n = 112; 69.1%) received the vaccine developed by Johnson & Johnson, which
only consists of one dose. However, some patients did report receiving both doses of the Pfizer
(n = 39; 24.1%) or the Moderna (n = 11; 6.8%) COVID-19 vaccines. Quite surprisingly, none of
the patients (0%) visiting the KRHSC between June and December 2021 reported receiving any
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sort of booster dose. However, booster doses were not applicable for the entire sample, as some
patients were not eligible at the time of review for boosters based on the date of their last
COVID-19 vaccination.
Unique patient visits to the center each month were also recorded as part of this
retrospective review. The month of June 2021 saw the highest patient volume (n = 96), followed
by November 2021 (n = 57) and October 2021 (n = 42). For each month, the percentage of those
fully vaccinated varied. The highest full vaccination percentages based on monthly unique visits
were observed for the months of June (n = 79; 82.3%), October (n = 27; 64.3%), July (n = 8;
61.5%), and September (n = 6; 60%), and the lowest vaccination percentages were seen in
November (n = 32; 56.1%), December (n = 5; 55.6%), and August (n = 5; 50%). The top four
months during which patients at the KRHSC reported receiving their last dose were April 2021
(n = 66), March 2021 (n = 45), May 2021 (n = 17), and July 2021 (n = 12), which align with the
vaccine rollouts of the U.S. Graphs 1 through 3 convey these results.
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Graph 1
Vaccine Type Breakdown for the KRHSC Patients, June to December 2021

Frequency of Vaccine Types
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Graph 2
Unique Patient Visits Per Month, June to December 2021
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Graph 3
Reported Date of Last Dose for Sample Patients, June to December 2021
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One of the primary objectives of this research study was to compare the KRHSC
vaccination rates with those published by Jefferson County and the state of Kentucky. According
to the Kentucky Department of Public Health, as of February 2022, a majority of Kentucky
residents 18 years of age and above (66%) are fully vaccinated against COVID-19. Out of those
who have received a first dose in the state, a small fraction of the population (n = 203,549; 7%)
received the Johnson & Johnson vaccine, while many more received either the Moderna (n =
1,108,414; 39%) or Pfizer (n = 1,558,989; 54%) vaccines. Kentucky has a low recorded rate of
booster doses (30%) for adults (Kentucky Department of Public Health, 2022). Specifically,
Jefferson County has the third highest vaccination percentage (73%) in the state for at least one
dose of any vaccine (Kentucky Department of Public Health, 2022). Additionally, a majority of
residents in Jefferson County are fully vaccinated (64.6%), but fewer people have received
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booster vaccinations (44.3%) against COVID-19 (Department of Public Health and Wellness,
2022).
Discussion
The initial hypothesis for this research study was partially supported. The KRHSC had a
higher fully vaccinated percentage (68.4%) from June to December 2021 than the reported
percentage for Kentucky (66%) through February 2022. This value represents ages 18 and up,
which was the same population studied at the KRHSC. This fully vaccinated data does not
include boosters or additional doses. As of December 2021, zero patients at the KRHSC reported
a booster dose compared to the rates for Kentucky (30%) or Jefferson County (44.3%) as
designated on the dashboards. This data supported the hypothesis that the KRHSC’s vaccination
rate would be lower than the state of Kentucky as it relates to boosters. The center also did have
an overall higher rate of full vaccination than Jefferson County (64.6%), which did not support
the hypothesis.
Limitations
This study did have some limitations. At the KRHSC, the high percentage of Johnson &
Johnson COVID-19 vaccinations was most likely explained by a requirement by Churchill
Downs, as reported to the KRHSC staff (Dr. Hayden and Dr. Krista Roach, MSN, APRN, FNPC, WHNP-BC) from patients. In order for this population to continue to work, workers were
required to be fully vaccinated. Several health fairs were held at the backside of Churchill Downs
to promote vaccinations in March, April, and July 2021. Johnson & Johnson was the primary
vaccine type used at these events. This may have been due to the fact that Johnson & Johnson’s
COVID-19 vaccination only requires one dose for full immunity, which could have lowered
costs for Churchill Downs and decreased the amount of patients required to follow-up for a
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second vaccine dose (in the case of Pfizer and Moderna), as many of the racetrack workers are
mobile and leave the state for other racetracks throughout the year. Since none of the patients
reported boosters as of December 2021, it is assumed that Churchill Downs is not requiring
additional doses of COVID-19 vaccines for backside racetrack workers. As previously
mentioned, booster vaccinations are essential for maintaining immunity, and each of the three
main COVID-19 vaccination types have different schedules for when boosters can be
administered. For example, for patients who received Johnson & Johnson’s vaccine, a booster is
recommended after at least 2 months (Centers for Disease Control and Prevention, 2022). The
highest frequencies of COVID-19 vaccinations for patients in this study occurred in the months
of the health fairs, and a large majority of these patients most likely require boosters based on the
CDC’s recommendations.
Another limitation in this retrospective study was the use of self-reported data from
patients at the KRHSC. Since these patients were directly asked about their vaccination status,
response bias may have been introduced and some of them may not have provided accurate
answers to these questions. This could have occurred if the participants wanted to provide
socially desirable responses (e.g., being vaccinated against COVID-19, even if they actually
were not). Additionally, patient access to the KRHSC impacted monthly appointments. The
lower rate of unique visits to the center during July and August may have been due to the
KRHSC being closed, and the sudden drop in visits between November and December could
have been caused by many of the racetrack workers leaving for the winter.
A major limitation of this study was a lack of access to archived vaccination records from
the Kentucky Department of Public Health. On the publicly available dashboards for COVID-19
vaccination data, it is not currently possible to view vaccination data for previous months. This
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may have led to some errors when comparing the results of this retrospective review to
vaccination rates for the state and Jefferson County. While past vaccination records may be
available in an online medium, they were not accessible to the author of this thesis.
A few patients reported why they did not want to receive any COVID-19 vaccine during
the triage process. The most common response for this was that they were afraid of the side
effects, as many of them had reported that family members or friends had long-term medical
issues after being vaccinated. Another typical reason for being unvaccinated was uncertainty of
the vaccines’ contents and the unfounded belief that these vaccines might cause more harm than
the actual COVID-19 infection. To assuage these fears, the nurse practitioners at the KRHSC
instructed these patients in the benefits of vaccination and how the risk for mortality and
negative side effects was actually higher for COVID-19 infection compared to any of the
available vaccines. The KRHSC providers also responded to this by providing a vaccination
campaign with a question and answer platform on Facebook Live that had over 2,000 views, as
reported to the author of this thesis by Dr. Hayden and Dr. Roach of the KRHSC.
Future studies have been considered to expand on the sustainability of this retrospective
review. Specifically, this research study could be continued by providing a questionnaire
developed by Kumari et al. (2021) to Latinx patients at the KRHSC. This questionnaire contains
detailed questions relating to patient attitudes about the COVID-19 vaccines. For example, one
question of interest on this questionnaire is, “In the present era, there are multiple sources of
information regarding a particular issue. How significantly have the following sources of
information influenced your opinion regarding vaccination?” Responses options include, “News
from National TV/Radio,” “Government agencies,” “Social media,” “Discussion amongst friends
and family,” and “Healthcare provider.” The questionnaire developed by Kumari et al. (2021)
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has thirty-nine items in total and was originally developed for use in India during the surge in
COVID-19 cases over summer 2021. This questionnaire has been validated through principal
component analysis, with a Kaiser-Meyer-Olkin value of 0.826 (values above 0.5 demonstrate
data that is suitable for factor analysis; Kumari et al., 2021). It is also reliable with a Cronbach’s
alpha value of 0.86 (Kumari et al., 2021). The authors of this paper have granted permission to
use this questionnaire for other patient population, with proper acknowledgement.
For a future research study, this questionnaire could be translated into Spanish to allow
Latinx patients at the KRHSC to answer the questions in their native language. The translation
should be properly verified, and simple descriptive statistics should be used to analyze all
collected data from the questionnaire. This questionnaire could easily be offered to patients
following their scheduled appointment time and would be presented on an iPad via Google
Forms.
This retrospective review was especially important because it focused entirely on Latinx
patients. This patient population should feel supported by healthcare professionals, as this may
help increase COVID-19 vaccination rates in the long run. Overall, this study addressed the
stated objectives and demonstrates promising results about COVID-19 vaccination rates at the
KRHSC. Further study will provide more insights about attitudes surrounding COVID-19
attitudes for patients at this center. The author of this thesis is looking forward to expanding the
scope of this study.
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